Kuros Biosciences AG Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Kuros Biosciences AG stock has a consensus rating of "Strong Buy" and an average price target of CHF 34.27. The average 1-year stock price forecast is 63.97% higher than the current stock price, while the lowest is CHF 32.00 (+53.11%) and the highest is CHF 38.00 (+81.82%).

Price Target: CHF 34.27 (+63.97%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	CHF 32.00	CHF 34.27	CHF 32.80	CHF 38.00
Change	+53.11%	+63.97%	+56.94%	+81.82%

* Price targets were last updated on Apr 14, 2026.

Analyst Ratings

The average analyst rating for Kuros Biosciences AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Jan '26	Feb '26	Mar '26	May '26	Jun '26
Strong Buy	0	1	1	1	1	1
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Christophe dombu Kepler Capital	Kepler Capital	Buy Maintains CHF 38.00	Buy	Maintains	CHF 38.00	+81.82%	Apr 14, 2026

Financial Forecast

Revenue This Year

211.81M

from 146.06M

45.02%

from 146.06M

Revenue Next Year

287.39M

from 211.81M

35.69%

from 211.81M

EPS This Year

0.27

from 0.06

346.64%

from 0.06

EPS Next Year

0.62

from 0.27

131.25%

from 0.27

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	15.15M	19.45M	39.86M	85.16M	146.06M	211.81M
Revenue Growth	231.96%	28.35%	104.92%	113.65%	71.51%	45.02%
Gross Profit	11.04M	15.54M	33.81M	75.67M	127.45M	186.18M
Gross Margin	72.86%	79.89%	84.83%	88.85%	87.26%	87.90%
Operating Income	-9.62M	-10.65M	-6.04M	120.00K	8.95M	19.52M
Net Income	-8.27M	-15.78M	-16.30M	-4.84M	2.55M	13.62M
EPS	-	-	-	-	0.06	0.27
EPS Growth	-	-	-	-	-	346.64%
Forward PE	-	-	-	-	-	96.74
Free Cash Flow	5.75M	-4.84M	-10.15M	4.63M	-3.93M	-8.28M
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	221.6M
Avg	211.8M
Low	202.1M

Revenue Growth

Revenue Growth	2026	2027	2028
High	51.7%
Avg	45.0%
Low	38.3%

EPS Forecast

EPS	2026	2027	2028
High	0.34
Avg	0.27
Low	0.19

EPS Growth

EPS Growth	2026	2027	2028
High	471.2%
Avg	346.6%
Low	222.1%